期刊
MICROBIAL PATHOGENESIS
卷 158, 期 -, 页码 -出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.micpath.2021.105024
关键词
African swine fever virus; Live-attenuated vaccines; Safety; Protective immunity
资金
- Innovation Project of the Chinese Academy of Agricultural Sciences [CAAS-ASTIP-2016-LVRI-05]
African swine fever (ASF) is a deadly infectious disease caused by ASFV with a complex genome, making vaccine development challenging. Recent advances in vaccine development, especially in live-attenuated vaccines, have been significant globally in combating ASF.
African swine fever (ASF) is an acute, hemorrhagic and severe infectious disease caused by African swine fever virus (ASFV) in domestic pigs and various wild boars, with a mortality rate up to 100%. ASF was first discovered in 1921 in Kenya. ASFV has a large genome and complex immune escape mechanism creating difficulties in the production of vaccines. Recently, remarkable advances have been made in vaccine development all over the world especially in live-attenuated vaccine. This article aims to review the research progress of ASF attenuated live vaccines in order to provide a reference for the development of vaccines for this disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据